 |
|
A Cluster of Transfusion-Associated Babesiosis Cases Traced to a Single Asymptomatic Donor
Joanna Dobroszycki, MD;
Barbara L. Herwaldt, MD, MPH;
Fouad Boctor, MD, PhD;
James R. Miller, MD, MPH;
Jeanne Linden, MD, MPH;
Mark L. Eberhard, PhD;
Jing Ja Yoon, MD;
Nahed M. Ali, DVM;
Herbert B. Tanowitz, MD;
Fitzroy Graham, BS;
Louis M. Weiss, MD, MPH;
Murray Wittner, MD, PhD
JAMA. 1999;281:927-930.
Context The risk of acquiring babesiosis by blood transfusion is largely unknown since in areas where it is endemic it is often an asymptomatic infection.
Objective To investigate and treat a cluster of blood transfusion–associated babesiosis cases.
Design Case series and epidemiologic investigation.
Setting Urban inner-city hospital.
Patients Six persons who received Babesia microti–infected blood components from a donor.
Main Outcome Measure Diagnosis and successful therapy of babesiosis following transfusion.
Results Six individuals (1 adult, 1 child, and 4 neonates) were exposed to products from a single blood donation by an asymptomatic Babesia-infected donor. Three of the 6 exposed patients became parasitemic. Polymerase chain reaction testing, animal inoculation studies, and indirect immunofluorescent antibody testing were used to confirm the presence of Babesia microti in the donor's blood and to establish the presence of infection in 3 of the 6 recipients. The 3 infected recipients and 1 additional recipient were treated without incident.
Conclusion Physicians should consider babesiosis in the differential diagnosis of a febrile hemolytic disorder after blood transfusion. Prompt diagnosis is important since babesiosis is responsive to antibiotic therapy and, untreated, can be a fatal disease in certain risk groups.
Author Affiliations: Departments of Pediatrics (Drs Dobroszycki and Yoon) and Pathology (Drs Boctor and Ali), Bronx-Lebanon Hospital Center, Bronx, NY; Centers for Disease Control and Prevention, Division of Parasitic Diseases, Atlanta, Ga (Drs Herwaldt and Eberhard); Parasitic Disease Surveillance Unit, New York City Department of Health, New York, NY (Dr Miller); New York State Department of Health, Albany, NY (Dr Linden); Departments of Pathology (Division of Parasitology and Tropical Medicine) (Drs Tanowitz, Weiss, and Wittner) and Medicine (Drs Tanowitz and Weiss), Albert Einstein College of Medicine, New York, NY; and Department of Pathology (Parasitology), Jacobi Medical Center, Bronx, NY (Mr Graham).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
March 10, 1999
JAMA. 1999;281(10):959-960.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Transfusion-Associated Babesiosis with an Atypical Time Course after Nonmyeloablative Transplantation for Sickle Cell Disease
Cirino et al.
ANN INTERN MED 2008;148:794-795.
FULL TEXT
Cellular Immunity, but Not Gamma Interferon, Is Essential for Resolution of Babesia microti Infection in BALB/c Mice
Clawson et al.
Infect. Immun. 2002;70:5304-5306.
ABSTRACT
| FULL TEXT
Cultivation of Babesia and Babesia-Like Blood Parasites: Agents of an Emerging Zoonotic Disease
Schuster
Clin. Microbiol. Rev. 2002;15:365-373.
ABSTRACT
| FULL TEXT
Antiparasitic Agent Atovaquone
Baggish and Hill
Antimicrob. Agents Chemother. 2002;46:1163-1173.
FULL TEXT
Laboratory-Acquired Parasitic Infections from Accidental Exposures
Herwaldt
Clin. Microbiol. Rev. 2001;14:659-688.
ABSTRACT
| FULL TEXT
The Treatment of Babesiosis
Weiss et al.
NEJM 2001;344:773-774.
FULL TEXT
Transfusion-Acquired, Autochthonous Human Babesiosis in Japan: Isolation of Babesia microti-Like Parasites with hu-RBC-SCID Mice
Saito-Ito et al.
J. Clin. Microbiol. 2000;38:4511-4516.
ABSTRACT
| FULL TEXT
Update on Transfusion Therapy
O'Connor and Apfelbaum
SEMIN CARDIOTHORAC VASC ANESTH 2000;4:236-243.
ABSTRACT
Serological Expression Cloning of Novel Immunoreactive Antigens of Babesia microti
Lodes et al.
Infect. Immun. 2000;68:2783-2790.
ABSTRACT
| FULL TEXT
|
